Guardant Health: Q4 Earnings Snapshot

In this article:

PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Guardant Health Inc. (GH) on Thursday reported a loss of $187 million in its fourth quarter.

On a per-share basis, the Palo Alto, California-based company said it had a loss of $1.58.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 93 cents per share.

The provider of oncology testing services posted revenue of $155.1 million in the period.

For the year, the company reported a loss of $479.4 million, or $4.28 per share. Revenue was reported as $563.9 million.

Guardant Health expects full-year revenue in the range of $655 million to $670 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH

Advertisement